$NTR

TD Securities and Scotiabank Take Different Views on Nutrien (NTR) after Q1 Results

After Nutrien’s Q1 results, TD Securities cut its price target to $83 from $86 and kept a Buy rating, citing expected phosphate margin pressure in Q2. On the same day, Scotiabank raised its target to $80 from $75 and maintained a Sector Perform rating, saying it is more positive despite near-term nitrogen price and regional grower-economics risks. CEO Ken Seitz said record potash volumes and improved Nitrogen/Retail performance supported results.

Original reporting
Published May 31, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 31, 2026, 4:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Securities and Scotiabank Take Different Views on Nutrien (NTR) after Q1 Results — source image
Decision brief

The 30-second read

$NTRNeutralMed
01

Why it matters

The trading takeaway is not the earnings recap itself, but the two analyst target moves with explicit drivers: TD’s phosphate-margin pressure expectation vs Scotiabank’s improving view despite nitrogen-price and regional grower-economics risks.

02

Market read

Divergent sell-side targets after Q1 can influence sentiment and positioning in fertilizer equities, especially around segment-specific margin expectations.

03

What to watch

The article highlights supply-chain strengthening and operational simplification; these could improve cost structure and cushion margin swings beyond near-term phosphate expectations.

Relevance 8/10Novelty 6/10Timing: Post-Q1 analyst target revisions (May 11) shaping current positioning

Background

Nutrien’s Q1 2026 call emphasized record potash sales volumes, stronger Nitrogen and Retail contributions, and operational simplification to improve capital efficiency.

Company-level read

Ticker impact

$NTRNeutralMedium confidence
Context

TD Securities cut its price target to $83 (from $86) after Q1 results, expecting phosphate margins pressure in Q2.

Expected impact

Near-term volatility likely as investors weigh phosphate-margin pressure vs. stronger segment performance and higher Scotiabank target.

Evidence & confidence

The article cites two specific, dated analyst target changes tied to Q1 read-through (phosphate margins vs nitrogen prices/grower economics), which can move positioning even without new company guidance.

Market effects

Fertilizer input names may see read-across sensitivity to phosphate margin expectations and nitrogen price dynamics.

Grower-economics challenges referenced by Scotiabank suggest continued regional demand/affordability pressure risk.

Tightening fertilizer markets and supply availability commentary implies global pricing and volume resilience remains a key debate.

Counterpoint

Record potash sales volumes and stronger Nitrogen/Retail results may offset phosphate-margin pressure more than TD assumes.

Key entities

  • Nutrien Ltd.

    Global crop inputs and ag retail provider; Q1 results and subsequent analyst target changes frame near-term margin and pricing expectations.

  • TD Securities

    Lowered its Nutrien price recommendation to $83 from $86; expects phosphate margins to come under pressure in Q2.

  • Scotiabank

    Raised its Nutrien price goal to $80 from $75; more positive despite near-term nitrogen price and regional grower-economics risks.

Related articles

$NTRMed

2 Dividend Stocks to Hold for the Next 7 Years

The article highlights two TSX dividend stocks for a 7-year hold. Nutrien (NTR) is described as a major crop-input and services provider; it trades near $97, with a 3.1% yield, after a 32% rise in six months. In Q1 2026 it reported net earnings of US$139m and adjusted EBITDA of US$1.1b. South Bow (SOBO) trades at $52.70 (5.2% yield) after a 47% rally; it reported ~616,000 bpd throughput and a 95% operating factor in the March quarter, and expects ~US$10m normalized EBITDA from the Blackrod Conne

$GDDYMed

Wall Street Is Losing Confidence in GoDaddy’s (GDDY) AI Strategy. Should Investors?

GoDaddy (NYSE:GDDY) reported Q results of $1.83 EPS and about $1.30B revenue, both above consensus, but the stock fell about 12%. Bookings rose 6% to $1.4B, while Applications and Commerce bookings growth slowed to 7% from 9%. Analysts cited concerns over agentic AI transition noise; management is accelerating Airo and cutting legacy investment. Q3 revenue guidance is $1.32B-$1.34B.

$BAMed

Boeing's 777X Headache Just Got Worse: Lufthansa Says No Thanks

Lufthansa said it will not accept the earliest built examples of Boeing’s 777-9, joining Emirates, as some aircraft have been in storage since 2019-2020. Boeing’s 777X program remains uncertified and is now about 6-7 years behind schedule, with certification targeted for late 2026 or early 2027 and first Lufthansa deliveries in Q1 2027. Boeing took a $4.9B pre-tax charge in 2025.